Whole genome sequencing in support of wellness and health maintenance

Genome Medicine

Volumn 5, Issue 6, 2013, Pages

  Patel, Chirag J ^a,b   Sivadas, Ambily ^c   Tabassum, Rubina ^c   Preeprem, Thanawadee ^c   Zhao, Jing ^c   Arafat, Dalia ^c   Chen, Rong ^a,b,d   Morgan, Alexander A ^a,b   Martin, Gregory S ^e   Brigham, Kenneth L ^e   Butte, Atul J ^a,b   Gibson, Greg ^c,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d Personalis   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

clinical profiling; genetic prediction; preventive medicine; risk assessment

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CONSULTATION; CORONARY ARTERY DISEASE; FAMILY HISTORY; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENOME; GENOTYPE; HEALTH; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; WELLBEING;

EID: 84879456976     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm462     Document Type: Article

References (40)

1. Thompson R, Drew CJ, Thomas RH. Next generation sequencing in the clinical domain: clinical advantages, practical, and ethical challenges. Adv Protein Chem Struct Biol 2012, 89:27-63.
2. Bick D, Dimmock D. Whole exome and whole genome sequencing. Curr Opin Pediatr 2011, 23:594-600. 10.1097/MOP.0b013e32834b20ec, 21881504.
3. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, Lee C, Smith JD, Turner EH, Stanaway IB, Vernot B, Malig M, Baker C, Reilly B, Akey JM, Borenstein E, Rieder MJ, Nickerson DA, Bernier R, Shendure J, Eichler EE. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250. 10.1038/nature10989, 3350576, 22495309.
4. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, Lin CF, Stevens C, Wang LS, Makarov V, Polak P, Yoon S, Maguire J, Crawford EL, Campbell NG, Geller ET, Valladares O, Schafer C, Liu H, Zhao T, Cai G, Lihm J, Dannenfelser R, Jabado O, Peralta Z, Nagaswamy U, Muzny D, Reid JG, Newsham I, Wu Y, Lewis L, Han Y, Voight BF, Lim E, Rossin E, Kirby A, Flannick J, Fromer M, Shakir K, Fennell T, Garimella K, Banks E, Poplin R, Gabriel S, DePristo M, Wimbish JR, Boone BE, Levy SE, Betancur C, Sunyaev S, Boerwinkle E, Buxbaum JD, Cook EH, Devlin B, Gibbs RA, Roeder K, Schellenberg GD, Sutcliffe JS, Daly MJ. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485:242-245. 10.1038/nature11011, 3613847, 22495311.
5. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL, Walker MF, Ober GT, Teran NA, Song Y, El-Fishawy P, Murtha RC, Choi M, Overton JD, Bjornson RD, Carriero NJ, Meyer KA, Bilguvar K, Mane SM, Sestan N, Lifton RP, Günel M, Roeder K, Geschwind DH, Devlin B, State MW. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241. 10.1038/nature10945, 3667984, 22495306.
6. Chou J, Ohsumi TK, Geha RS. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2012, 12:623-628. 10.1097/ACI.0b013e3283588ca6, 23095910.
7. Ghosh S, Krux F, Binder V, Gombert M, Niehues T, Feyen O, Laws HJ, Borkhardt A. PID-NET: German Network on Primary Immunodeficiency Diseases: Array-based sequence capture and next-generation sequencing for the identification of primary immunodeficiencies. Scand J Immunol 2012, 75:350-354. 10.1111/j.1365-3083.2011.02658.x, 22017423.
8. Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, McDonald MT, Meisler MH, Goldstein DB. Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet 2012, 49:353-361. 10.1136/jmedgenet-2012-100819, 3375064, 22581936.
9. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet 2012, 90:7-24. 10.1016/j.ajhg.2011.11.029, 3257326, 22243964.
10. Ku CS, Loy EY, Pawitan Y, Chia KS. The pursuit of genome-wide association studies: where are we now?. J Hum Genet 2010, 55:195-206. 10.1038/jhg.2010.19, 20300123.
11. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, Manning AK, Florez JC, Wilson PW, D'Agostino RB, Cupples LA. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008, 359:2208-2219. 10.1056/NEJMoa0804742, 2746946, 19020323.
12. Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, Berglund G, Altshuler D, Nilsson P, Groop L. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008, 359:2220-2232. 10.1056/NEJMoa0801869, 19020324.
13. Feero WG, Guttmacher AE, Collins FS. Genomic medicine - an updated primer. N Engl J Med 2010, 362:2001-2011. 10.1056/NEJMra0907175, 20505179.
14. Chen R, Butte AJ. The reference human genome demonstrates high risk of type 1 diabetes and other disorders. Pac Symp Biocomput 2011, 231-242.
15. Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, Dudley JT, Ormond KE, Pavlovic A, Morgan AA, Pushkarev D, Neff NF, Hudgins L, Gong L, Hodges LM, Berlin DS, Thorn CF, Sangkuhl K, Hebert JM, Woon M, Sagreiya H, Whaley R, Knowles JW, Chou MF, Thakuria JV, Rosenbaum AM, Zaranek AW, Church GM, Greely HT, Quake SR, Altman RB. Clinical assessment incorporating a personal genome. Lancet 2010, 375:1525-1535. 10.1016/S0140-6736(10)60452-7, 2937184, 20435227.
16. Dewey FE, Chen R, Cordero SP, Ormond KE, Caleshu C, Karczewski KJ, Whirl-Carrillo M, Wheeler MT, Dudley JT, Byrnes JK, Cornejo OE, Knowles JW, Woon M, Sangkuhl K, Gong L, Thorn CF, Hebert JM, Capriotti E, David SP, Pavlovic A, West A, Thakuria JV, Ball MP, Zaranek AW, Rehm HL, Church GM, West JS, Bustamante CD, Snyder M, Altman RB, Klein TE, Butte AJ, Ashley EA. Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet 2011, 7:e1002280. 10.1371/journal.pgen.1002280, 3174201, 21935354.
17. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Chen R, Miriami E, Karczewski KJ, Hariharan M, Dewey FE, Cheng Y, Clark MJ, Im H, Habegger L, Balasubramanian S, O'Huallachain M, Dudley JT, Hillenmeyer S, Haraksingh R, Sharon D, Euskirchen G, Lacroute P, Bettinger K, Boyle AP, Kasowski M, Grubert F, Seki S, Garcia M, Whirl-Carrillo M, Gallardo M, Blasco MA, Greenberg PL, Snyder P, Klein TE, Altman RB, Butte AJ, Ashley EA, Gerstein M, Nadeau KC, Tang H, Snyder M. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148:1293-1307. 10.1016/j.cell.2012.02.009, 3341616, 22424236.
18. Gupta R, Ratan A, Rajesh C, Chen R, Kim HL, Burhans R, Miller W, Santhosh S, Davuluri RV, Butte A, Schuster SC, Seshagiri S, Thomas G. Sequencing and analysis of a South Asian-Indian personal genome. BMC Genomics 2012, 13:440. 10.1186/1471-2164-13-440, 3534380, 22938532.
19. Chen R, Corona E, Sikora M, Dudley JT, Morgan AA, Moreno-Estrada A, Nilsen GB, Ruau D, Lincoln SE, Bustamante CD, Butte AJ. Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases. PLoS Genet 2012, 8:e1002621. 10.1371/journal.pgen.1002621, 3325177, 22511877.
20. Goetzel RZ, Ozminkowski RJ. The health and cost benefits of work site health-promotion programs. Annu Rev Public Health 2008, 29:303-323. 10.1146/annurev.publhealth.29.020907.090930, 18173386.
21. Omenn GS. Overview of the symposium on public health significance of genomics and eco-genetics. Annu Rev Public Health 2010, 31:1-8. 10.1146/annurev.publhealth.012809.103639, 20001819.
22. Healthy People 2020 Framework The vision, mission, and goals of Health People 2020. 2012, Accessed October 30, Healthy People 2020 Framework., http://www.healthypeple.gov
23. Brigham KL. Predictive health: the imminent revolution in health care. J Am Geriatr Soc 2010, 58(Suppl 2):S298-302. 3760012, 21029057.
24. Rask KJ, Brigham KL, Johns MME. Integrating comparative effectiveness research programs into predictive health: A unique role for academic health centers. Acad Med 2011, 86:718-723. 10.1097/ACM.0b013e318217ea6c, 21512361.
25. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753. 10.1161/CIRCULATIONAHA.107.699579, 18212285.
26. Framingham Heart Study. Risk score profiles. http://www.framinghamheartstudy.org/risk/index.html
27. Morgan AA, Chen R, Butte AJ. Likelihood ratios for genome medicine. Genome Med 2010, 2:30. 10.1186/gm151, 2887074, 20497613.
28. Pelak K, Shianna KV, Ge D, Maia JM, Zhu M, Smith JP, Cirulli ET, Fellay J, Dickson SP, Gumbs CE, Heinzen EL, Need AC, Ruzzo EK, Singh A, Campbell CR, Hong LK, Lornsen KA, McKenzie AM, Sobreira NL, Hoover-Fong JE, Milner JD, Ottman R, Haynes BF, Goedert JJ, Goldstein DB. The characterization of twenty sequenced human genomes. PLoS Genet 2010, 6:e1001111. 10.1371/journal.pgen.1001111, 2936541, 20838461.
29. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do R, Liu X, Jun G, Kang HM, Jordan D, Leal SM, Gabriel S, Rieder MJ, Abecasis G, Altshuler D, Nickerson DA, Boerwinkle E, Sunyaev S, Bustamante CD, Bamshad MJ, Akey JM, Broad GO, Seattle GO, NHLBI Exome Sequencing Project Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012, 337:64-69. 10.1126/science.1219240, 3708544, 22604720, NHLBI Exome Sequencing Project.
30. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL. The human disease network. Proc Natl Acad Sci USA 2007, 104:8685-8690. 10.1073/pnas.0701361104, 1885563, 17502601.
31. Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk of complex disease. Curr Opin Genet Dev 2008, 18:257-263. 10.1016/j.gde.2008.07.006, 18682292.
32. Zhao J, Arafat D, Gibson G. Genetic risk prediction in a small cohort of healthy adults in Atlanta. Genet Res (Camb) 2013, 95:30-37. 10.1017/S0016672313000025, 23442331.
33. Breslow JL, Zannis VI, SanGiacomo TR, Third JL, Tracy T, Glueck CJ. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2. J. Lipid Res 1982, 23:1224-1235.
34. Do CB, Hinds DA, Francke U, Eriksson N. Comparison of family history and SNPs for predicting risk of complex disease. PLoS Genet 2012, 8:e1002973. 10.1371/journal.pgen.1002973, 3469463, 23071447.
35. Evans DM, Visscher PM, Wray NR. Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk. Hum Mol Genet 2009, 18:3525-3531. 10.1093/hmg/ddp295, 19553258.
36. Kruppa J, Ziegler A, König IR. Risk estimation and risk prediction using machine-learning methods. Hum Genet 2012, 131:1639-1654. 10.1007/s00439-012-1194-y, 3432206, 22752090.
37. Wray NR, Yang J, Goddard ME, Visscher PM. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genetics 2010, 6:e1000864. 10.1371/journal.pgen.1000864, 2829056, 20195508.
38. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood AR, Weyant RJ, Segrè AV, Speliotes EK, Wheeler E, Soranzo N, Park JH, Yang J, Gudbjartsson D, Heard-Costa NL, Randall JC, Qi L, Vernon Smith A, Mägi R, Pastinen T, Liang L, Heid IM, Luan J, Thorleifsson G, Winkler TW, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010, 467:832-838. 10.1038/nature09410, 2955183, 20881960.
39. Green RC, Berg JS, Berry GT, Biesecker LG, Dimmock DP, Evans JP, Grody WW, Hedge MR, Kalia S, Korf BR, Krantz I, McGuire AL, Miller DT, Murray MF, Nussbaum RL, Plon SE, Rehm HL, Jacob HJ. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med 2012, 14:405-410. 10.1038/gim.2012.21, 3763716, 22422049.
40. Shen H, Li J, Zhang J, Xu C, Jiang Y, Wu Z, Zhao F, Liao L, Chen J, Lin Y, Tian Q, Papasian CJ, Deng HW. Comprehensive characterization of human genome variation by high coverage whole-genome sequencing of forty four Caucasians. PLoS One 2013, 8:e59494. 10.1371/journal.pone.0059494, 3618277, 23577066.